查看购物车
  • Traditional Chinese
  • English
  • Japanese
创伤护理管理(WCM)的世界市场规模，趋势，分析:各产品类型，各地区，市场区隔预测(～2033年)
市场调查报告书
商品编码
1366556

创伤护理管理(WCM)的世界市场规模，趋势，分析:各产品类型，各地区，市场区隔预测(～2033年)

Wound Care Management (WCM) Market Size, Trends and Analysis by Product Type, Region and Segment Forecast to 2033
出版日期: | 出版商: GlobalData | 英文 614 Pages | 订单完成后即时交付

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球伤口护理管理 (WCM) 市场规模预计将在 2023 年达到 300 亿美元，在预测期内（2023-2033 年）复合年增长率为 3.8%。该市场主要由伤口护理管理技术进步、手术数量增加、人口老化和慢性病盛行率所推动。这使得企业能够优化每个接触点并改善整体客户体验。

本报告提供全球创伤护理管理(WCM)市场相关调查分析，提供主要的推动要素与课题，主要指标的预测，企业简介等资讯。

目录

第1章 摘要整理

第2章 调查范围和市场区隔

  • 创伤护理管理(WCM):市场区隔和范围
  • 创伤护理管理(WCM):市场定义

第3章 创伤护理管理(WCM) - 产业趋势的分析

  • 创伤护理管理(WCM) - 推动市场要素
  • 创伤护理管理(WCM) - 阻碍市场要素
  • 创伤护理管理(WCM) - 法规形势
  • 创伤护理管理(WCM) - 宏观趋势

第4章 创伤护理管理(WCM)的全球预测

  • 全球创伤护理管理(WCM)市场 - 收益概述
  • 全球创伤护理管理(WCM):详细的市场规模的估计
  • 全球创伤护理管理(WCM)的商机:各产品类型
  • 全球WCM市场 - 各地区(2021年～2033年)

第5章 创伤护理管理(WCM)的地区预测

  • 创伤护理管理(WCM) - 地区概要与分析
  • 北美的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 北美的创伤护理管理(WCM)的商机:各产品类型(2021年～2033年)
    • 美国的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 加拿大的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 墨西哥的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
  • 欧洲的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 欧洲的创伤护理管理(WCM)的商机:各产品类型(2021年～2033年)
    • 法国的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 德国的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 义大利的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 西班牙的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 荷兰的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 瑞士的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 英国的创伤护理管理(WCM)市场 - 概要(2021年～2033年)
    • 其他的欧洲的创伤护理管理(WCM)市场 - 概要(2021年～2033年)

第6章 竞争情形

  • 创伤护理管理:竞争情形概要
  • 创伤护理管理:企业占有率分析

第7章 企业简介

  • 3M Co
  • AbbVie Inc
  • B. Braun Melsungen AG
  • Becton Dickinson and Co
  • Baxter International Inc
  • Cardinal Health
  • Coloplast Corp
  • Convatec Group Plc
  • BSN medical GmbH (Essity AB)
  • Integra LifeSciences Holdings Corp
  • Investor AB (Molnlycke Health Care AB)
  • Johnson & Johnson
  • Medline Industries LP
  • Medtronic Plc
  • Mimedx Group, Inc.
  • Paul Hartmann AG
  • Smith & Nephew Plc
  • Stryker Corp
  • Tactile Systems Technology Inc.
  • Teleflex Inc
  • Sechrist Industries Inc
  • Perry Baromedical Corporation
  • Haux-Life-Support GmbH

第8章 调查手法

第9章 关于GlobalData

简介目录
Product Code: GRCBBR00002ME

Abstract

The Wound Care Management (WCM) market will be valued at $30.0 billion in 2023 and is expected to grow at a CAGR of 3.8% over the forecast period (2023-2033). The WCM report provides an executive-level overview of the wounf care industry worldwide today, with detailed forecasts of key indicators up to 2033.

This market intelligence report offers a thorough, forward-looking analysis of the global Wound Care Management (WCM) market by product type, regional segments, and key opportunities in a concise format to help executives build proactive and profitable growth strategies.

Wound Care Management (WCM) market will be valued at $30.0 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.8% over the forecast period. The wound care management market comprises of dressings, equipment and other aids to prevent, treat wounds and also quicken or promote wound healing. The wound care management market covers advanced wound management, compression therapy, hyperbaric oxygen chambers, negative pressure wound therapy (NPWT), ostomy drainage bags, pressure relief devices, surgical sutures, tissue engineered - skin substitutes, traditional wound management, wound closure devices and wound debridement devices. The market is largely driven due to technological advancements in wound care management, increase in number of surgical procedures, ageing population, and increase in prevalence of chronic diseases. This helps businesses optimize each touchpoint and enhance the overall customer experience.

Scope

  • This report provides overview and service addressable market for global Wound Care Management (WCM) market
  • It identifies the key drivers and challenges impacting growth of the WCM market over the next 12 to 24 months.
  • It includes global market forecasts for the WCM market and analysis of latest M&A deals, regulatory trends, and reimbursement scenario.
  • It covers detailed segmentation by product type and regional segmentation.

Reasons to Buy

  • This market intelligence report offers a thorough, forward-looking analysis of the global Wound Care Management (WCM) market by product type, regional segments, and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData's Forecast products, the report examines the drivers, challenges, trend analysis in the WCM market.
  • Detailed segmentation by product type traditional wound management, wound dressings, compression therapy, npwt (negative pressure wound therapy) devices, ostomy drainage bags, tissue sealants and adhesives, surgical sutures, tissue engineered skin substitutes, pressure relief devices, ligating clips, topical absorbable hemostats, oxygen therapy devices, wound contact layers, surgical adhesion barriers, and others (wound closure strips, superabsorbents, and wound debridement devices). Further, the report also highlights segmentation by region.
  • The report includes 100+ charts and tables providing in-depth analysis of the market size, forecast, and supporting factors which are tailor-made for an executive-level audience, with enhanced presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from local market players, which enables executives to quickly get up to speed with the current and emerging trends in WCM markets.
  • The competitive section of the report helps in identifying the flagbearers, experimenters, contenders, and specialists based on their growth and innovation performance in the WCM industry which will help stakeholders analyze competition penetration.
  • The broad perspective of the report, coupled with comprehensive, actionable detail, will help WCM vendors and other companies succeed in the growing WCM market globally.

Table of Contents

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Research Scope and Segmentation

  • 2.1 Wound Care Management (WCM): Market Segmentation and Scope
  • 2.2 Wound Care Management (WCM): Market Definitions

Chapter 3 Wound Care Management (WCM) - Industry Trend Analysis

  • 3.1 Wound Care Management (WCM) - Market Drivers
  • 3.2 Wound Care Management (WCM) - Market Restraints
  • 3.3 Wound Care Management (WCM) - Regulatory Landscape
  • 3.4 Wound Care Management (WCM) - Macroeconomic Trends

Chapter 4 Wound Care Management (WCM) Global Outlook

  • 4.1 Global Wound Care Management (WCM) Market - Revenue Snapshot ($ Billion)
  • 4.2 Global Wound Care Management (WCM): Detailed Market Size Estimates
  • 4.3 Global Wound Care Management (WCM) Revenue Opportunity by Product Type
  • 4.4 Global WCM Market - By Region, 2021-2033 ($ Million)

Chapter 5 Wound Care Management (WCM) Regional Outlook

  • 5.1 Wound Care Management (WCM) - Regional Overview & Analysis
  • 5.2 North America Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Billion)
    • 5.2.1 North America Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.2.2 US Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.2.2.1 US Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.2.3 Canada Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.2.3.1 Canada Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.2.4 Mexico Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.2.4.1 Mexico Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
  • 5.3 Europe Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Billion)
    • 5.3.1 Europe Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.2 France Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.2.1 France Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.3 Germany Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.2.1 Germany Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.4 Italy Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.4.1 Italy Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.5 Spain Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.5.1 Spain Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.6 The Netherlands Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.6.1 The Netherlands Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.7 Switzerland Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.7.1 Switzerland Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.8 UK Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.8.1 UK Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.9 Rest of Europe Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.9.1 Rest of Europe Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)

Chapter 6 Competitive Landscape

  • 6.1 Wound Care Management: Competitive Landscape Overview
  • 6.2 Wound Care Management: Company Share Analysis

Chapter 7 Company Profiles

  • 7.1 3M Co
    • 7.1.1 3M Co: WCM Offerings
    • 7.1.2 3M Co: Financials
    • 7.1.3 3M Co: SWOT Analysis
    • 7.1.4 3M Co: Key Personnel
  • 7.2 AbbVie Inc
    • 7.2.1 AbbVie Inc: WCM Offerings
    • 7.2.2 AbbVie Inc: Financials
    • 7.2.3 AbbVie Inc: SWOT Analysis
    • 7.2.4 AbbVie Inc: Key Personnel
  • 7.3 B. Braun Melsungen AG
    • 7.3.1 B. Braun Melsungen AG: WCM Offerings
    • 7.3.2 B. Braun Melsungen AG: Financials
    • 7.3.3 B. Braun Melsungen AG: SWOT Analysis
    • 7.3.4 B. Braun Melsungen AG: Key Personnel
  • 7.4 Becton Dickinson and Co
    • 7.4.1 Becton Dickinson and Co: WCM Offerings
    • 7.4.2 Becton Dickinson and Co: Financials
    • 7.4.3 Becton Dickinson and Co: SWOT Analysis
    • 7.4.4 Becton Dickinson and Co: Key Personnel
  • 7.5 Baxter International Inc: Overview
    • 7.5.1 Becton Dickinson and Co: WCM Offerings
    • 7.5.2 Becton Dickinson and Co: Financials
    • 7.5.3 Becton Dickinson and Co: SWOT Analysis
    • 7.5.4 Becton Dickinson and Co: Key Personnel
  • 7.6 Cardinal Health: Overview
    • 7.6.1 Cardinal Health: WCM Offerings
    • 7.6.2 Cardinal Health: Financials
    • 7.6.3 Cardinal Health: SWOT Analysis
    • 7.6.4 Cardinal Health: Key Personnel
  • 7.7 Coloplast Corp: Overview
    • 7.7.1 Coloplast Corp: WCM Offerings
    • 7.7.2 Coloplast Corp: Key Personnel
  • 7.8 Convatec Group Plc: Overview
    • 7.8.1 Convatec Group Plc: WCM Offerings
    • 7.8.2 Convatec Group Plc: Financials
    • 7.8.3 Convatec Group Plc: SWOT Analysis
    • 7.8.4 Convatec Group Plc: Key Personnel
  • 7.9 BSN medical GmbH (Essity AB): Overview
    • 7.9.1 BSN medical GmbH (Essity AB): WCM Offerings
    • 7.9.2 BSN medical GmbH (Essity AB): SWOT Analysis
    • 7.9.3 BSN medical GmbH (Essity AB): Key Personnel
  • 7.10 Integra LifeSciences Holdings Corp: Overview
    • 7.10.1 Integra LifeSciences Holdings Corp: WCM Offerings
    • 7.10.2 Integra LifeSciences Holdings Corp: Financials
    • 7.10.3 Integra LifeSciences Holdings Corp: SWOT Analysis
    • 7.10.4 Integra LifeSciences Holdings Corp: Key Personnel
  • 7.11 Investor AB (Molnlycke Health Care AB): Overview
    • 7.11.1 Investor AB (Molnlycke Health Care AB): WCM Offerings
    • 7.11.2 Investor AB (Molnlycke Health Care AB): Financials
    • 7.11.3 Investor AB (Molnlycke Health Care AB): SWOT Analysis
    • 7.11.4 Investor AB (Molnlycke Health Care AB): Key Personnel
  • 7.12 Johnson & Johnson: Overview
    • 7.12.1 Johnson & Johnson: WCM Offerings
    • 7.12.2 Johnson & Johnson: Financials
    • 7.12.3 Johnson & Johnson: SWOT Analysis
    • 7.12.4 Johnson & Johnson: Key Personnel
  • 7.13 Medline Industries LP: Overview
    • 7.13.1 Medline Industries LP: WCM Offerings
  • p7.13.2 Medline Industries LP: SWOT Analysis
    • 7.13.3 Medline Industries LP: Key Personnel
  • 7.14 Medtronic Plc: Overview
    • 7.14.1 Medtronic Plc: WCM Offerings
    • 7.14.2 Medtronic Plc: Financials
    • 7.14.3 Medtronic Plc: SWOT Analysis
    • 7.14.4 Medtronic Plc: Key Personnel
  • 7.15 Mimedx Group, Inc.: Overview
    • 7.15.1 Mimedx Group, Inc: WCM Offerings
    • 7.15.2 Mimedx Group, Inc: Financials
    • 7.15.3 Mimedx Group, Inc: Key Personnel
  • 7.16 Paul Hartmann AG: Overview
    • 7.16.1 Paul Hartmann AG: WCM Offerings
    • 7.16.2 Paul Hartmann AG: Financials
    • 7.16.3 Paul Hartmann AG: SWOT Analysis
    • 7.16.4 Paul Hartmann AG: Key Personnel
  • 7.17 Smith & Nephew Plc: Overview
    • 7.17.1 Smith & Nephew Plc: WCM Offerings
    • 7.17.2 Smith & Nephew Plc: Financials
    • 7.17.3 Smith & Nephew Plc: SWOT Analysis
    • 7.17.4 Smith & Nephew Plc: Key Personnel
  • 7.18 Stryker Corp: Overview
    • 7.18.1 Stryker Corp: WCM Offerings
    • 7.18.2 Stryker Corp: Financials
    • 7.18.3 Stryker Corp: SWOT Analysis
    • 7.18.4 Stryker Corp: Key Personnel
  • 7.19 Tactile Systems Technology Inc.: Overview
    • 7.19.1 Tactile Systems Technology Inc.: WCM Offerings
    • 7.19.2 Tactile Systems Technology Inc.: Financials
    • 7.19.3 Tactile Systems Technology Inc.: SWOT Analysis
    • 7.19.4 Tactile Systems Technology Inc.: Key Personnel
  • 7.20 Teleflex Inc: Overview
    • 7.20.1 Teleflex Inc: WCM Offerings
    • 7.20.2 Teleflex Inc: Financials
    • 7.20.3 Teleflex Inc: SWOT Analysis
    • 7.20.4 Teleflex Inc: Key Personnel
  • 7.21 Sechrist Industries Inc: Overview
    • 7.21.1 Sechrist Industries Inc: WCM Offerings
    • 7.21.2 Sechrist Industries Inc: Key Personnel
  • 7.22 Perry Baromedical Corporation: Overview
    • 7.22.1 Perry Baromedical Corporation: WCM Offerings
    • 7.22.2 Perry Baromedical Corporation: Key Personnel
  • 7.23 Haux-Life-Support GmbH: Overview
    • 7.23.1 Haux-Life-Support GmbH: WCM Offerings

Chapter 10 Research Methodology

Chapter 11 About GlobalData